Board of Directors
Janet S. Vergis
Ms. Vergis, 49, has served as an Executive-in-Residence at Warburg Pincus, LLC, a global private equity firm, since January 2013, where she identifies and evaluates healthcare investment opportunities. From January 2010 to August 2012, she was the Chief Executive Officer of OraPharma, Inc., a specialty pharmaceutical company dedicated to oral health, where she led the company’s successful turnaround and sale to Valeant Pharmaceuticals International, Inc. From 1988 to 2009, she served in various positions of increasing responsibility in executive leadership, research and development, new product development, sales and marketing with Johnson & Johnson and its subsidiaries. Her most recent role was as President of Janssen Pharmaceuticals, McNeil Pediatrics and Ortho- McNeil Neurologics. Ms. Vergis is a member of the board of directors of K-V Pharmaceutical Company, a specialty branded pharmaceutical company with a primary focus on women’s healthcare.
Ms. Vergis’s more than 25 years of pharmaceutical leadership experience, together with her extensive background in research and development, new product development, sales and marketing, combined with her focus in the areas of oral health and women’s health, will enable her to provide important perspectives to our Board of Directors.